Research Radboudumc Technology Centers Image-guided treatments MITeC News The collaboration with Siemens Healthineers

22 December 2020

An extensive program has been set up together with Siemens Healthineers in which structural, scientific research is being conducted into promising procedures. We spoke with Siemens Healthineers about our partnership.

What makes MITeC unique?

MITeC is unique in Europe for its combination of technological development and determination of clinical relevance through evidence-based research. It is a field lab where doctors, companies and researchers can develop new procedures and techniques. MITeC not only provides facilities, but a special research methodology, with which the added value of new technology or treatment methods can be determined at an early stage. Innovations that can be tested for their potential to actually contribute to better and more affordable care. The design phase of the interior was unique as well. A test set-up of the ORs was set up with customized tailor-made operating tables, computer screens and two life-size tailor-made inflatable imaging systems. Changing scenarios were reenacted in a team and it was examined what the best setup was for the practice.

What is the added value of your collaboration with MITeC?

The continued development of existing and new imaging equipment is not possible without close collaboration with doctors, researchers and technical physicians. They see opportunities to increase the quality of minimally invasive procedures and shorten the duration of treatment. Based on their wishes, we implement technological improvements and prepare them for practice.

MITeC performs a broad spectrum of clinical research projects with the goal of improving treatment precision and effectiveness. Clinical and research competences of the entire MITeC team provides a valuable platform for exchange of the new ideas and innovative concepts. Especially the deep knowledge in the field of evidence-based medicine and health technology assessment drives research in a way that benefits not only patients but the healthcare delivery system in general. In addition, their expertise in translation research, in for example MR guided prostate interventions, makes MITeC unique.

How can MITeC (and our collaboration) contribute to developments in healthcare in the future?

Partnerships with excellent collaboration sites such as MITeC supports Siemens Healthineers not only to develop, to test and to validate our new solutions for minimally invasive image guided interventions in the clinical environment, but also to evaluate its success rate from the clinical and economical point of view in the earliest stages of development. Together we building the components in support of the ultimate goal of MITeC : “one day surgery for oncology patients”.

We are proud of the inspiring collaboration with Prof. Maroeska Rovers and Prof. Jurgen Fütterer and their team. They bring concrete, demonstrable improvements in minimally invasive treatments, as well as the shortening of care processes. Patients can be treated faster and more effectively and therefore rehabilitate better. In addition, the health technology assessments ensure that the new procedures and techniques are more cost-efficient than the existing ones. In this way we keep high-quality care affordable now and in the future.

 

Kees Smaling, managing director of Siemens Healthineers
Sjaak van der Pouw, director Innovation at Siemens Healthineers
Rebecca Fahrig, vice president Innovation Advanced Therapies at Siemens Healthineers
Arne Hengerer, head MRI Guided Therapies at Siemens Healthineers

Related news items


Liver tumors irradiated from inside can be followed live from outside

17 February 2022 A Dutch research team from Radboud University Medical Center has visualized the injection of radioactive microspheres during treatment of a patient with liver tumors ‘live on screen’. read more

LUMO Labs and Oost NL invest in Aiosyn Investment accelerates development of artificial intelligence platform to improve diagnostics

7 February 2022 Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor. read more

Large AI project receives over €95 million for ten years of public-private research

23 September 2021 The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs. read more

New start-up Patholyt will bring AI research into pathology diagnostics

21 September 2021 Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research. read more

Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview

22 July 2021 Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map. read more

Working visit queen Máxima

8 March 2021 In November 2015, queen Máxima opened the three innovative operation rooms of MITeC. On 28 January 2021, she wanted to come back to hear and see what was done and accomplished the last years. read more